John L. Erb

John L. Erb is a declared insider at 5 companies (board member); the most frequent names are Vascular Solutions Inc, Nuwellis, Inc. and Senorx Inc. We count 67 filings; the first trade dates from 28 February 2007 and the latest from 10 June 2025.

On the open market, the record shows 15 purchases worth €188k and 19 sales worth €1.4M. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 16 share grants and 10 option exercises.

A typical purchase (the median) is worth €5,367. Of 7 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 11 June 2025 came the latest disclosure, a transaction for €395 in Nuwellis, Inc. The last insider purchase was made public on 30 March 2023, 1,304 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.